Successful eradication of inhibitor of late recurrence and other high risk prognostic factors in a patient with severe haemophilia A

Haemophilia. 2011 Sep;17(5):e833-4. doi: 10.1111/j.1365-2516.2011.02571.x. Epub 2011 May 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Blood Coagulation Factor Inhibitors / analysis*
  • Factor VIII / immunology
  • Factor VIII / therapeutic use*
  • Hemophilia A / drug therapy
  • Hemophilia A / immunology*
  • Humans
  • Immune Tolerance / drug effects*
  • Immunologic Factors / therapeutic use*
  • Male
  • Recombinant Proteins / therapeutic use
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Blood Coagulation Factor Inhibitors
  • Immunologic Factors
  • Recombinant Proteins
  • Rituximab
  • Factor VIII